Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
halothane | Solution | 250 mL | |
ketamine | Injection | 50 mg (as hydrochloride)/mL in 10-mL vial | |
nitrous oxide | Inhalation | N/A | |
oxygen | Inhalation (medicine gas) | N/A | |
propofol | Aqueous emulsion | 200 mg/ 20 ml | |
thiopental | Powder for injection | 0.5 g (as sodium) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bupivacaine | Solution for injection | 5 mg/ml | |
bupivacaine + glucose | Injection | 0.5%/ 80 mg/ml | |
ephedrine | Injection | 50 mg/ml | |
lidocaine | Injection | 2% (hydrochloride) in 2 mL ampoule | |
lidocaine | Ointment | 5% (hydrochloride) | |
lidocaine + epinephrine (adrenaline) | Dental cartridge | 2% (hydrochloride) + epinephrine 1:80 000 | |
lidocaine + epinephrine (adrenaline) | Injection | 2% / 1:100 000 |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atropine | Injection | 250 mcg/mL | |
diazepam | Injection | 10 mg in 2-mL ampoule | |
fentanyl | Injection | 50 mcg (citrate)/mL | |
midazolam | Injection | 15 mg/3 ml | |
morphine | Injection | 10 mg/ml | |
promethazine | Injection | 25mg (hydrochloride)/ml | |
promethazine | Oral solution | 1mg/mL | |
promethazine | Tablet | 25 mg | |
sufentanil | Injection | 50 mcg/mL (5 mL) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
diclofenac | Injection | 25 mg (sodium)/mL | |
diclofenac | Suppository | 100 mg (as sodium) | |
ibuprofen | Tablet | 200 mg | |
ibuprofen | Tablet | 400 mg | |
methylsalicylate | Ointment | 10% | |
naproxen | Tablet | 250 mg | |
paracetamol | Oral liquid | 120 mg/5 mL | |
paracetamol | Suppository | 1 g | |
paracetamol | Suppository | 120 mg | |
paracetamol | Suppository | 240 mg | |
paracetamol | Suppository | 500 mg | |
paracetamol | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
codeine | Tablet | 30 mg | |
fentanyl | Patch | 100 mcg/hr | |
fentanyl | Patch | 12 mcg/hr | |
fentanyl | Patch | 25 mcg/hr | |
morphine | Oral liquid | 2 mg/mL (hydrochloride) | |
morphine | Solid oral dosage form | 10 mg | |
morphine | Tablet (controlled release) | 10 mg | |
morphine | Tablet (controlled release) | 30 mg | |
morphine | Tablet (controlled release) | 60 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
allopurinol | Tablet | 100 mg | |
allopurinol | Tablet | 300 mg | |
colchicine | Tablet | 0.5mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
azathioprine | Tablet | 50 mg | |
ciclosporin | Capsule | 25 mg | |
ciclosporin | Capsule | 50 mg | |
hydroxychloroquine | Tablet | 200 mg | |
methotrexate | Tablet | 2.5 mg | |
penicillamine | Capsule | 250 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cetirizine | Tablet | 10 mg | |
chlorphenamine | Injection | 10 mg (hydrogen maleate) in 1-ml ampoule | |
chlorphenamine | Oral liquid | 2 mg/5 ml (hydrogen maleate) | |
chlorphenamine | Tablet | 4 mg (hydrogen maleate) | |
cinnarizine | Tablet | 25 mg | |
dexamethasone | Injection | 4 mg (phosphate)/mL | |
dexamethasone | Tablet | 0.5 mg | |
dexamethasone | Tablet | 1 mg | |
epinephrine (adrenaline) | Injection | 1 mg in 1-mL ampoule | |
hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
prednisolone | Tablet | 30 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atropine | Injection | 1 mg (sulfate) in 1-ml ampoule | |
calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
deferoxamine | Powder for injection | 500 mg | |
methylthioninium chloride (methylene blue) | Injection | 10 mg/ml in 10-ml ampoule | |
naloxone | Injection | 400 mcg (hydrochloride) in 1-mL ampoule | |
penicillamine | Capsule | 250 mg | |
potassium ferric hexacyano-ferrate(II) - 2H20 (Prussian blue) | Powder for oral administration | N/A | |
pralidoxime | Injection | 200 mg/mL (mesilate) | |
sodium calcium edetate | Injection | 200 mg/ml in 5-ml ampoule | |
sodium nitrite | Injection | 30 mg/mL in 10-mL ampoule | |
sodium thiosulfate | Injection | 250 mg/mL in 50-mL ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbamazepine | Tablet (chewable) | 100 mg | |
carbamazepine | Tablet (chewable) | 200 mg | |
clonazepam | Tablet | 2mg | |
diazepam | Injection | 10 mg in 2-mL ampoule | |
magnesium sulfate | Injection | 200 mg/mL in 10-mL ampoule | |
phenobarbital | Tablet | 100 mg | |
phenobarbitone | Injection | 100 mg/mL | |
phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
phenytoin | Solid oral dosage form | 100 mg (sodium salt) | |
valproic acid (sodium valproate) | Oral liquid | 60 mg/mL | |
valproic acid (sodium valproate) | Tablet (controlled release) | 300 mg (enteric coated) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
albendazole | Tablet (chewable) | 400 mg | |
ivermectin | Tablet | 3 mg | |
mebendazole | Tablet | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
praziquantel | Tablet | 600 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amoxicillin | Suspension | 125 mg/ 5 ml | |
amoxicillin | Suspension | 250 mg/5ml | |
amoxicillin | Tablet | 500 mg | |
amoxicillin | Tablet | 500 mg | |
amoxicillin + clavulanic acid | Powder for injection | 1g + 0.2g | |
amoxicillin + clavulanic acid | Powder for injection | 500mg/ 50 mg | |
ampicillin | Powder for injection | 1 g | |
ampicillin | Powder for injection | 500 mg | |
benzathine benzylpenicillin | Injection | 2 400 000 IU | |
benzathine benzylpenicillin | Powder for injection | 1 200 000 UI | |
benzylpenicillin | Powder for injection | 1 million IU | |
flucloxacillin | Oral liquid | 125 mg/5 mL (sodium salt) | |
flucloxacillin | Oral liquid | 250mg/5ml (sodium salt) | |
flucloxacillin | Powder for injection | 500 mg | |
flucloxacillin | Tablet | 500 mg | |
phenoxymethylpenicillin | Tablet | 250 mg (as potassium salt) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amikacin | Injection | 250 mg/mL in 2-mL vial | |
azithromycin | Tablet | 250 mg | |
cefazolin | Injection | 1g | |
cefotaxime | Powder for injection | 250 mg | |
ceftriaxone | Powder for injection | 1 g (as sodium salt) in vial | |
ceftriaxone | Powder for injection | 2 g (as sodium) in vial | |
ceftriaxone | Powder for injection | 250 mg (as sodium salt) in vial | |
ceftriaxone | Powder for injection | 500 mg | |
ciprofloxacin | Tablet | 250 mg | |
ciprofloxacin | Tablet | 500 mg | |
co-trimoxazole | Injection | 96 mg/ml x 5 ml IV | |
co-trimoxazole | Suspension | 240 mg/5 ml | |
co-trimoxazole | Tablet | 480 mg | |
doxycycline | Tablet | 100mg | |
erythromycin | Oral suspension | 125 mg/5 mL (ethylsuccinate) | |
erythromycin | Powder for injection | 1 g (lactiobonate) | |
erythromycin | Tablet | 250 mg | |
gentamicin | Injection | 10 mg (sulfate)/mL in 2-mL vial | |
gentamicin | Injection | 40 mg (sulfate)/ml in 2-mL vial | |
meropenem | Powder for injection | 500mg | |
metronidazole | Injection | 500 mg in 100-mL vial | |
metronidazole | Suspension | 200 mg/ 5 ml | |
neomycin | Solid oral dosage form | 250 mg (sulfate) | |
nitrofurantoin | Tablet | 100 mg | |
nitrofurantoin | Tablet | 50mg | |
spectinomycin | Powder for injection | 2 g (as hydrochloride) in vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clofazimine | Solid oral dosage form | 100 mg | |
clofazimine | Solid oral dosage form | 50 mg | |
dapsone | Tablet | 100 mg | |
dapsone | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ethambutol | Tablet | 400mg | |
ethambutol + isoniazid + pyrazinamide + rifampicin | Tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
ethambutol + isoniazid + rifampicin | Tablet | 275 mg + 75 mg + 150 mg | |
isoniazid | Tablet | 100mg | |
isoniazid | Tablet | 300mg | |
isoniazid + rifampicin | Tablet | 150 mg + 300 mg | |
isoniazid + rifampicin | Tablet | 75 mg + 150 mg | |
pyrazinamide | Tablet | 500 mg | |
rifampicin | Oral liquid | 20 mg/ml | |
rifampicin | Solid oral dosage form | 150 mg | |
rifampicin | Solid oral dosage form | 300 mg | |
streptomycin | Powder for injection | 1 g |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amphotericin B | Powder for injection | 50 mg in vial | |
fluconazole | Tablet | 200 mg | |
flucytosine | Capsule | 250 mg | |
griseofulvin | Tablet | 125 mg | |
griseofulvin | Tablet | 500mg | |
ketoconazole | Tablet | 200 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
metronidazole | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
pentamidine | Powder for injection | 300 mg (isetionate) in ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
artemether + lumefantrine | Tablet | 20 mg + 120 mg | |
artesunate | Injection | ampoules, containing 60 mg anhydrous artesunic acid with a separate ampoule of 5% sodium bicarbonate solution | |
artesunate | Tablet | 100 mg | |
doxycycline | Tablet | 100mg | |
mefloquine | Tablet | 250 mg (hydrochloride) | |
primaquine | Tablet | 15 mg (as diphosphate) | |
primaquine | Tablet | 7.5 mg (as diphosphate) | |
quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
abacavir | Suspension | 20 mg/ml x 240 ml | |
abacavir | Tablet | 300 mg | |
efavirenz (EFV or EFZ) | Tablet | 600 mg | |
efavirenz (EFV or EFZ) | Tablet (scored) | 200 mg | |
lamivudine (3TC) | Oral solution | 10mg/mL (100mL) | |
lamivudine (3TC) | Oral solution | 10mg/mL (240mL) | |
lamivudine (3TC) | Tablet | 150 mg | |
lamivudine + nevirapine + stavudine | Tablet | 150 mg + 200 mg + 30 mg | |
lamivudine + nevirapine + zidovudine | Tablet | 150 mg + 200 mg + 300 mg | |
lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
lopinavir + ritonavir (LPV/r) | Capsule | 133.3 mg + 33.3 mg | |
lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
nevirapine (NVP) | Suspension | 10mg/ml | |
nevirapine (NVP) | Tablet | 200 mg | |
stavudine (d4T) | Tablet | 30 mg | |
tenofovir | Tablet | 300 mg | |
zidovudine (ZDV or AZT) | Oral liquid | 10 mg/mL (100 mL) | |
zidovudine (ZDV or AZT) | Oral liquid | 10 mg/mL (300 mL) | |
zidovudine (ZDV or AZT) | Solid oral dosage form | 100 mg | |
zidovudine (ZDV or AZT) | Solid oral dosage form | 300 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
benznidazole | Tablet | 100 mg | |
benznidazole | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylsalicylic acid | Tablet | 500 mg | |
paracetamol | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
propranolol | Tablet | 40 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
azathioprine | Tablet | 50 mg | |
ciclosporin | Capsule | 25 mg | |
ciclosporin | Capsule | 50 mg | |
methylprednisolone | Injection | 40 mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
all trans retinoid acid (ATRA) | Capsule | 10 mg | |
asparaginase | Powder for injection | 10 000 IU in vial | |
bleomycin | Powder for injection | 15 mg (as sulfate) in vial | |
capecitabine | Tablet | 150 mg | |
capecitabine | Tablet | 500 mg | |
chlorambucil | Tablet | 2 mg | |
chlormethine | Powder for injection | 10 mg | |
cisplatin | Powder for injection | 10 mg in vial | |
cyclophosphamide | Powder for injection | 200 mg | |
cyclophosphamide | Powder for injection | 500 mg in vial | |
cytarabine | Powder for injection | 100 mg in vial | |
dacarbazine | Powder for injection | 200 mg | |
dactinomycin | Powder for injection | 500 mcg in vial | |
docetaxel | Injection | 20 mg/ml | |
doxorubicin | Powder for injection | 10 mg in vial | |
doxorubicin | Powder for injection | 50 mg in vial | |
etoposide | Injection | 20 mg/mL in 5-mL ampoule | |
fluorouracil | Injection | 50 mg/ml in 5-ml ampoule | |
mercaptopurine | Tablet | 50 mg | |
methotrexate | Injection | L.P.F 25MG/ML X 2ML | |
methotrexate | Tablet | 2.5 mg (as sodium salt) | |
oxaliplatin | Injection | 100 mg/ 20 ml in 20 ml vial | |
oxaliplatin | Injection | 50 mg/ 10 ml in 10 ml vial | |
paclitaxel | Powder for injection | 6 mg/ml | |
procarbazine | Capsule | 50 mg (as hydrochloride) | |
thalidomide | Solid oral dosage form | 100 mg | |
vinblastine | Powder for injection | 10 mg (sulfate) in vial | |
vincristine | Injection | 1 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
calcium folinate | Injection | 10 mg/mL | |
calcium folinate | Tablet | 15 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anastrozole | Tablet | 1mg | |
bicalutamide | Tablet | 150 mg | |
bicalutamide | Tablet | 50 mg | |
conjugated estrogens | Tablet | 1.25 mg | |
dexamethasone | Injection | 4 mg (phosphate)/mL | |
dexamethasone | Solid oral dosage form | 1.5 mg | |
medroxyprogesterone acetate | Tablet | 100 mg | |
prednisolone | Tablet | 30 mg | |
prednisolone | Tablet | 5 mg | |
tamoxifen | Tablet | 20 mg (as citrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
hydroxycarbamide | Solid oral dosage form | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
biperiden | Tablet | 2 mg (hydrochloride) | |
levodopa + carbidopa | Tablet | 100 mg/ 25 mg | |
levodopa + carbidopa | Tablet | 200 mg/ 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ferrous fumarate | Oral liquid | 6 mg/mL | |
ferrous fumarate | Tablet | 200 mg | |
folic acid | Tablet | 0.5mg | |
hydroxocobalamin | Injection | 1 mg/mL | |
hydroxycarbamide | Solid oral dosage form | 500 mg | |
iron + dextran complex | Injection | 50 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
desmopressin | Nasal spray | 0.1 mg (acetate)/mL | |
heparin sodium | Injection | 5000 IU/mL in 5-mL vial | |
nadroparina | Injection | 9500 IU Anti-Xa/ml (0.3ml) | |
phenprocoumon | Tablet | 3 mg | |
phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
phytomenadione | Injection | 2 mg/ml | |
phytomenadione | Tablet | 10 mg | |
protamine sulfate | Injection | 10 mg/mL in 5-mL ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
polygeline | Injection | 3.5% in 500ml vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
albumin | Injection | 20% | |
anti-D immunoglobulin (human) | Injection | 500 IU | |
factor IX | N/A | N/A | |
factor VIII | Solution for injection | 500 UI | |
plasma protein fraction | Injection | 4% (100mL) Pasteurized |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bisoprolol | Tablet | 1.25 mg | |
bisoprolol | Tablet | 2.5 mg | |
bisoprolol | Tablet | 5 mg | |
isosorbide dinitrate | Tablet (prolonged release) | 20 mg | |
isosorbide dinitrate | Tablet (sublingual) | 5 mg | |
verapamil | Tablet | 40 mg (hydrochloride) | |
verapamil | Tablet | 80 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amiodarone | Injection | 50 mg/mL in 3-mL ampoule (hydrochloride) | |
amiodarone | Tablet (HCI) | 200 mg (hydrochloride) | |
bisoprolol | Tablet | 1.25 mg | |
bisoprolol | Tablet | 2.5 mg | |
bisoprolol | Tablet | 5 mg | |
digoxin | Injection | 250 micrograms/mL in 2-mL ampoule | |
digoxin | Oral liquid | 50 micrograms/mL | |
digoxin | Tablet | 250 mcg | |
digoxin | Tablet | 62.5 micrograms | |
isoprenaline | Injection | 1 mg/mL | |
lidocaine | Injection | 1% (hydrochloride) | |
procainamide | Injection | 100 mg (hydrochloride)/mL | |
sotalol | Tablet | 80 mg | |
verapamil | Injection | 2.5 mg (hydrochloride)/mL in 2-mL ampoule | |
verapamil | Tablet (prolonged release) | 120 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amlodipine | Tablet | 10 mg | |
amlodipine | Tablet | 5 mg | |
bisoprolol | Tablet | 1.25 mg | |
bisoprolol | Tablet | 2.5 mg | |
bisoprolol | Tablet | 5 mg | |
enalapril | Tablet | 20 mg | |
enalapril | Tablet | 5 mg | |
hydralazine | Solution for injection | 20 mg/ ml | |
hydralazine | Tablet | 50 mg (hydrochloride) | |
hydrochlorothiazide | Tablet (scored) | 25 mg | |
losartan | Tablet | 50mg | |
methyldopa | Tablet | 250 mg | |
sodium nitroprusside | Injection | 10 mg/mL/5 mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bisoprolol | Tablet | 1.25 mg | |
bisoprolol | Tablet | 2.5 mg | |
bisoprolol | Tablet | 5 mg | |
digoxin | Injection | 250 micrograms/mL in 2-mL ampoule | |
digoxin | Oral liquid | 50 micrograms/mL | |
digoxin | Tablet | 250 mcg | |
digoxin | Tablet | 62.5 micrograms | |
dobutamine | Injection | 250 mg | |
dopamine | Injection | 40 mg/mL (hydrochloride) in 5-mL vial | |
enalapril | Tablet | 20 mg | |
enalapril | Tablet | 5 mg | |
furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
furosemide | Tablet | 40 mg | |
hydrochlorothiazide | Tablet (scored) | 25 mg | |
losartan | Tablet | 50mg | |
spironolactone | Tablet | 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylsalicylic acid | Tablet | 80 mg | |
streptokinase | Powder for injection | 1.5 million IU in vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
simvastatin | Tablet | 20 mg | |
simvastatin | Tablet | 40 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
miconazole | Cream | 2% (nitrate) | |
miconazole | Vaginal cream | 2% (nitrate) | |
salicyclic acid + benzoic acid | Cream | 5%/ 5% | |
selenium sulfide | Detergent-based suspension | 2% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
fusidic acid | Ointment | 2% | |
gentian violet | Solution | 1% | |
iodine-povidone | Ointment | 10% | |
iodine-povidone | Solution | 10% | |
mupirocin | Ointment | 2% (nasal ointment) | |
potassium permanganate | Solution | 0.1% | |
silver sulfadiazine | Cream | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
betamethasone | Cream | 0.1% (as valerate) | |
calamine | Lotion | 15% | |
clobetasol | Cream | 0.05% | |
clobetasol | Lotion | 0.05% (propionate) | |
hydrocortisone | Cream | 1% (acetate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
benzoyl peroxide | Gel | 5% | |
coal tar | paste | 5% | |
fluorouracil | Ointment | 5% | |
podophyllum resin | Solution | 10% to 25% | |
salicylic acid | Cream | 10%- 20% | |
salicylic acid | Solution | 5%-10% | |
urea | Cream | 10% | |
urea | Cream | 5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
benzyl benzoate | Lotion | 25% | |
permethrin | Cream | 5% | |
permethrin | Lotion | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clindamycin | Solution | 1% | |
methoxsalen | Solution | 0.15% | |
tretinoin | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
fluorescein | Injection | 50mg/mL (disodium) | |
fluorescein | strips | N/A | |
tropicamide | Solution (eye drops) | 0.5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
barium sulfate | Powder for enema | 400 g | |
barium sulfate | Powder for oral suspension | 150 g | |
ethyl esters of iodinated fatty acids of poppy oil | Injection | 480 mg/mL | |
iohexol | Injection | 240 mg/mL | |
iopamidol (iopromide) | Intravenous administration | Equiv 300 mg iodine in 20 mL-vial | |
iopamidol (iopromide) | Intravenous administration | Equiv300 mg iodine in 50 mL vial | |
ioxaglic acid | Injection | 320 mg/mL | |
metrizoic acid | Solution | 100mg/L (bladder fluid) | |
metrizoic acid | Solution | 350 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorhexidine | mouth wash | 0.2% | |
chlorhexidine | Solution | 0.5% alcohol solution (digluconate) | |
hydrogen peroxide | Solution | 3% | |
iodine-povidone | Solution | 10% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glutaraldehyde | Solution | 2% | |
sodium hypochlorite | Solution | 0.25% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
furosemide | Tablet | 40 mg | |
hydrochlorothiazide | Tablet (scored) | 25 mg | |
mannitol | Injectable solution | 10% | |
spironolactone | Tablet | 25 mg | |
triamterene | Solid oral dosage form | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aluminum + magnesium hydroxide | Suspension | N/A | |
aluminum + magnesium hydroxide | Tablet | 300mg/ 200mg | |
cimetidine | Injection | 100 mg/mL | |
omeprazole | Tablet | 20 mg | |
omeprazole | Tablet | 40 mg | |
ranitidine | Tablet | 150 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dexamethasone | Tablet | 4 mg | |
dimenhydrinate | Suppository | 10 mg | |
dimenhydrinate | Suppository | 50 mg | |
domperidone | Tablet | 10 mg | |
metoclopramide | Injection | 5 mg (hydrochloride)/mL in 2-mL ampoule | |
ondansetron | Tablet | 4 mg | |
ondansetron | Tablet | 8 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
beclometasone | enema | 3 mg | |
mesalazine | enema | 1G | |
mesalazine | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
butyl scopolamine | Injection | 20 mg/ml | |
butyl scopolamine | Tablet | 10mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
loperamide | Solid oral dosage form | 2mg | |
oral rehydration salts | Powder for dilution | 1 L | |
zinc sulfate | Solid oral dosage form | 20 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glibenclamide | Tablet | 5 mg | |
Insulin | Injection | (intermediate acting) 100U/mL in 10 mL | |
Insulin | Injection | (long acting) 100U/mL in 10 mL | |
Insulin | Injection | (short acting) 100U/mL in 10 mL | |
metformin | Tablet | 500 mg | |
tolbutamide | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dexamethasone | Solid oral dosage form | 0.5 mg | |
dexamethasone | Solid oral dosage form | 1.5 mg | |
fludrocortisone | Tablet | 0.1 mg | |
hydrocortisone | Injection | 100 mg (as sodium succinate) | |
hydrocortisone | Tablet | 20 mg | |
methylprednisolone | Powder for injection | 500 mg (succinate) in vial | |
prednisolone | Injection | 25 mg/mL | |
prednisolone | Tablet | 30 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
testosterone | Injection | 250mg/ mL in 1 mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
desogestrel | Tablet | 0.075 mg | |
ethinylestradiol + levonorgestrel | Tablet | 3-phase 30microg + 50microg/ 40microg + 75microg/ 30microg + 125microg | |
ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg | |
ethinylestradiol + levonorgestrel | Tablet | 50 mcg/ 250 mcg | |
levonorgestrel | Tablet | 1.5 mg | |
levonorgestrel | Tablet | 30 micrograms | |
levonorgestrel-releasing implant | N/A | Two-rod levonorgestrel-releasing implant, each rod containing 75 mg of levonorgestrel (150 mg total) | |
medroxyprogesterone acetate | Depot injection | 150 mg/mL in 1-mL vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
copper-containing device | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
condoms | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clomiphene citrate | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
Lynestrenol | Tablet | 5 mg | |
norethisterone | Tablet | 5mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbimazole | Tablet | 5 mg | |
levothyroxine | Tablet | 100 mcg (sodium salt) | |
levothyroxine | Tablet | 25 mcg (sodium salt) | |
levothyroxine | Tablet | 50 mcg (sodium salt) | |
potassium iodide | Solution | 10% | |
tiamazol | Tablet | 30 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
desmopressin | Nasal solution | 0.1 mg (acetate)/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
triamcinolone | Injection | (acetonide) 10 mg/mL in 1 mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
tuberculin, purified protein derivative (PPD) | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anti-hepatitis B immunoglobulin | Solution for injection | 150 IU | |
antitetanus immunoglobulin (human) | Solution for injection | 250 IU | |
polyvalent anti snake venom serum | Injection | 10ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
diphtheria and tetanus toxoid | Injection | pediatric | |
diphtheria, tetanus toxoid | Injection | adult | |
diphtheria, tetanus toxoid + pertussis vaccine | Injection | N/A | |
MMR vaccine | Injection | measles, mumps and rubella live virus | |
pentavalent vaccine | Injection | diphtheria-tetanu toxoid, whole cell pertussis, hepatitis B, H. influenzae b (Hib) | |
poliomyelitis vaccine | Oral liquid | N/A | |
yellow fever vaccine | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
hepatitis B vaccine | Injection | adult | |
hepatitis B vaccine | Injection | pediatric | |
human papilloma virus (HPV) vaccine | N/A | N/A | |
rabies vaccine | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
baclofen | Tablet | 10 mg | |
baclofen | Tablet | 25 mg | |
neostigmine | Injection | 500 mcg (methylsulfate) in 1-mL ampoule | |
pancuronium | Injection | 2 mg (bromuro)/mL | |
pyridostigmine | Tablet | 60 mg (bromide) | |
rocuronium bromide | Solution for injection | 50 mg/ 5 ml | |
suxamethonium | Injection | 50 mg (chloride)/ml in 2-ml ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aciclovir | Eye ointment | 3% | |
gentamicin | Eye ointment | (sulfate) 0.5% | |
gentamicin | Solution (eye drops) | 0.3% (sulfate) | |
tetracycline | Eye ointment | 1% (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dexamethasone | Solution (eye drops) | 0.1% | |
prednisolone | Eye ointment | 0.5% (5mg/g) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
phenylephrine | Solution (eye drops) | 1.25mg/ml (5ml) (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
lidocaine | Solution (eye drops) | 4% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetazolamide | Tablet | 250 mg | |
dorzolamide | Solution (eye drops) | 2% | |
dorzolamide + timolol | eye drops | 2%/ 0.5% | |
latanoprost | Solution (eye drops) | 0.005% | |
pilocarpine | Solution (eye drops) | 2% (hydrochloride) | |
pilocarpine | Solution (eye drops) | 4% (hydrochloride) | |
timolol | Solution (eye drops) | 0.5 % |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atropine | Solution (eye drops) | 0.5% (sulfate) | |
atropine | Solution (eye drops) | 1% (sulfate) | |
homatropine | Solution (eye drops) | 2% | |
phenylephrine | Solution (eye drops) | 10% | |
phenylephrine | Solution (eye drops) | 15% | |
phenylephrine | Solution (eye drops) | 5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbomer | Eye gel | 3 mg/mL (0.03%) | |
diclofenac | Solution (eye drops) | 0.1% | |
hypromellose | Solution (eye drops) | 0.3% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetic acid | ear drops | 0.7% | |
beclometasone | Nasal spray | 50 mcg | |
lidocaine | drops | 0.5% (5 mL) | |
miconazole | drops | 2% | |
oxymethazoline | Nasal spray | 0.25 mg/ml | |
oxymethazoline | Nasal spray | 0.5 mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ergometrine | Injection | 0.2 mg/mL (maleate) in 1-mL ampoule | |
misoprostol | Tablet | 200 mcg | |
oxytocin | Injection | 10 IU in 1-mL ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
nifedipine | Tablet | 20 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amino acids | Injection | 8% | |
lipid emulsion | Emulsion | 10% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
chlorpromazine | Tablet | 100 mg | |
flufenazine | Tablet | 5 mg (hydrochloride) | |
flufenazine decanoate | Solution for injection | 25 mg/ ml | |
haloperidol | Injection | 100 mg/mL (decanoate) | |
haloperidol | Injection | 5 mg/mL in 1-mL ampoule | |
haloperidol | Oral liquid | 2 mg/mL | |
haloperidol | Tablet | 2 mg | |
haloperidol | Tablet | 5 mg | |
pimozide | Tablet | 1 mg | |
pimozide | Tablet | 4 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
citalopram | Tablet | 20 mg | |
maprotiline | Tablet | 25 mg (hydrochloride) | |
maprotiline | Tablet | 75 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbamazepine | Tablet (chewable) | 100 mg | |
carbamazepine | Tablet (chewable) | 200 mg | |
lithium carbonate | Tablet (controlled release) | 400 mg | |
valproic acid (sodium valproate) | Tablet | 300 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clorazepate | Capsule | 5 mg | |
diazepam | Injection | 10 mg in 2-mL ampoule | |
diazepam | Tablet (scored) | 10 mg | |
diazepam | Tablet (scored) | 5 mg | |
lorazepam | Tablet (scored) | 2.5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clomipramine | Solid oral dosage form | 10 mg | |
clomipramine | Solid oral dosage form | 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
nicotine replacement therapy (NRT) | Chewing gum | 4 mg (as polacrilex) | |
nicotine replacement therapy (NRT) | Transdermal patches | 14 mg/ 24 hr |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
beclometasone | Inhalation (aerosol) | 100 micrograms (dipropionate) per dose (as CFC free forms) | |
ipratropium bromide | Inhalation (aerosol) | 20 micrograms/metered dose | |
salbutamol | Inhalation (aerosol) | 100 mcg (as sulfate) per dose | |
salbutamol | Injection | 1 mg/ mL - 5 mL | |
salbutamol | Oral liquid | 2 mg/5 mL | |
salbutamol | respirator solution for use in nebulizers | 5 mg (as sulfate)/mL | |
theophylline | Tablet | 175 mg | |
theophylline | Tablet | 350 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
codeine | Tablet | 10mg | |
cough expectorant liquid | N/A | Mixtura Resolvens |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
caffeine citrate | Injection | 20 mg/ml (equivalent to 10 mg caffeine base/ml) | |
caffeine citrate | Oral liquid | 20 mg/ml (equivalent to 10 mg caffeine base/ml) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aluminum hydroxide | Tablet | 500 mg | |
calcium acetate/ magnesium carbonate | Tablet | 435 mg/235 mg | |
oral rehydration salts | Powder for dilution | 1 L | |
potassium chloride | Oral solution | 75 mg/mL | |
sodium polystrene sulphonate | Powder | 454 g |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glucose | Parenteral formulation | 10% (100mL) | |
glucose | Parenteral formulation | 10% (500 mL) | |
glucose | Parenteral formulation | 40% (20mL) | |
glucose | Parenteral formulation | 40% (50mL) | |
glucose | Parenteral formulation | 5% (100 mL) | |
glucose | Parenteral formulation | 5% (500 mL) | |
glucose with sodium chloride | injection for intravenous administration | 2.5% glucose + 0.45% sodium chloride (500 mL) | |
glucose with sodium chloride | injection for intravenous administration | 5% glucose + 0.9% sodium chloride (500 mL) | |
glucose with sodium chloride | Solution for IV infusion injection | 3.75%/ 0.225% (500mL) | |
potassium chloride | Injection | 7.46% | |
sodium bicarbonate | Injection | 8.4% | |
sodium bicarbonate | Injection | 8.4% (100mL) | |
sodium bicarbonate | Solution for IV infusion | 1.4% (100mL) | |
sodium chloride | Parenteral formulation | 0.9% (100 mL) | |
sodium chloride | Parenteral formulation | 0.9% (1000mL) | |
sodium chloride | Parenteral formulation | 0.9% (500 mL) | |
sodium chloride | Parenteral formulation | 20% (30mL) | |
sodium lactate co hartman full | injection for intravenous administration | 500 mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
water for injection | N/A | 10-ml ampoules | |
water for injection | N/A | 30 mL | |
water for injection | N/A | 5-mL ampoules |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
alfacalcidol | Tablet | 0.25 mcg | |
ascorbic acid | Tablet | 50 mg | |
calcium gluconate | Injection | 9.5mg/ml (10mL) | |
cholecalciferol | Oral solution | 50000 IU/mL (100mL) | |
pyridoxine | Tablet | 50 mg | |
retinol | Capsule | 50 000 IU (as palmitate) | |
retinol | Oral solution | (palmitate) 100.000 IU/ml (100ml) | |
thiamine | Tablet | 50 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
abacavir | Tablet | 300 mg | |
abacavir (ABC) | Oral liquid | 20mg/ml | |
efavirenz (EFV or EFZ) | Tablet | 600 mg | |
efavirenz (EFV or EFZ) | Tablet (scored) | 200 mg | |
lamivudine (3TC) | Oral solution | 10mg/mL (100mL) | |
lamivudine (3TC) | Oral solution | 10mg/mL (240mL) | |
lamivudine (3TC) | Tablet | 150 mg | |
lamivudine + nevirapine + stavudine | Tablet | 150 mg + 200 mg + 30 mg | |
lamivudine + nevirapine + zidovudine | Tablet | 150 mg + 200 mg + 300 mg | |
lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
lopinavir + ritonavir (LPV/r) | Capsule | 133.3 mg + 33.3 mg | |
lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
nevirapine (NVP) | Suspension | 10mg/ml | |
nevirapine (NVP) | Tablet | 200 mg | |
stavudine (d4T) | Capsule | 30 mg | |
tenofovir | Tablet | 300 mg | |
zidovudine (ZDV or AZT) | Oral liquid | 10 mg/mL (100 mL) | |
zidovudine (ZDV or AZT) | Oral liquid | 10 mg/mL (300 mL) | |
zidovudine (ZDV or AZT) | Solid oral dosage form | 100 mg | |
zidovudine (ZDV or AZT) | Solid oral dosage form | 300 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anti-D immunoglobulin (human) | Injection | 500 IU | |
azithromycin | Tablet | 250 mg | |
bromocriptine mesylate | Tablet | 2.5 mg | |
clarithromycin | Tablet | 500 mg | |
diloxanide | Tablet | 500 mg (furoate) | |
erythropoetin | Injection | 4,000 IU | |
factor IX | N/A | N/A | |
factor VIII | Solution for injection | 500 UI | |
fluconazole | Tablet | 200 mg | |
human normal immunoglobulin | Injection | 10% | |
iron + dextran complex | N/A | 50 mg/ml | |
losartan | Tablet | 50mg | |
macrogol | Powder for solution | 4 g | |
melphalan | Tablet | 2 mg | |
mesalazine | Tablet | 500 mg | |
methylphenidate | Tablet | 10 mg | |
methylprednisolone | Injection | 500 mg (sodium succinate) | |
mifepristone + misoprostol | Tablet | Mifepristone 200mg tab (1) and Misoprostol 200 mcg (4) combo pack | |
nadroparina | Injection | 9500 IU Anti-Xa/ml (0.3ml) | |
octreotide | Injection | 0.2 mg/ml (1ml) | |
ondansetron | Tablet | 4 mg | |
ondansetron | Tablet | 8 mg | |
pralidoxime | Injection | 200 mg/mL (mesilate) | |
sufentanil | Injection | 50 mcg/mL (5 mL) | |
tamsulosin | Tablet | 0.4 mg | |
thalidomide | Tablet | 100 mg | |
vinblastine | Injection | 10 mg |